Inverness Counsel’s UnitedHealth UNH Stock Holding History

Inverness Counsel’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$52.9M	Sell	104,795 -26,572	-20%	-$14M	2.94%	8
2022 Q2	$67.5M	Sell	131,367 -4,642	-3%	-$2.33M	3.79%	7
2022 Q1	$69.4M	Sell	136,009 -1,860	-1%	-$897K	3.11%	9
2021 Q4	$69.2M	Sell	137,869 -25,238	-15%	-$11.4M	2.55%	13
2021 Q3	$63.7M	Buy	163,107 +2,934	+2%	+$1.22M	2.34%	13
2021 Q2	$64.1M	Buy	160,173 +1,722	+1%	+$687K	2.34%	13
2021 Q1	$59M	Buy	158,451 +21,256	+15%	+$7.37M	2.44%	10
2020 Q4	$48.1M	Sell	137,195 -4,380	-3%	-$1.47M	1.97%	17
2020 Q3	$44.1M	Sell	141,575 -220	-0.2%	-$67.6K	1.97%	19
2020 Q2	$41.8M	Buy	141,795 +16,696	+13%	+$4.78M	2.08%	12
2020 Q1	$31.2M	Buy	125,099 +2,569	+2%	+$707K	1.96%	15
2019 Q4	$36M	Sell	122,530 -12,953	-10%	-$3.39M	1.7%	22
2019 Q3	$29.4M	Sell	135,483 -2,656	-2%	-$641K	1.52%	29
2019 Q2	$33.7M	Sell	138,139 -42,303	-23%	-$10.2M	1.72%	22
2019 Q1	$44.6M	Sell	180,442 -24,281	-12%	-$6.19M	2.43%	11
2018 Q4	$51M	Sell	204,723 -23,028	-10%	-$6.08M	3.42%	6
2018 Q3	$60.6M	Buy	227,751 +4,997	+2%	+$1.3M	3.19%	6
2018 Q2	$54.6M	Sell	222,754 -7,191	-3%	-$1.73M	3.11%	6
2018 Q1	$49.2M	Buy	229,945 +15,508	+7%	+$3.54M	2.96%	6
2017 Q4	$47.3M	Buy	214,437 +16,715	+8%	+$3.54M	2.97%	5
2017 Q3	$38.7M	Sell	197,722 -11,147	-5%	-$2.15M	2.73%	5
2017 Q2	$38.7M	Sell	208,869 -4,832	-2%	-$847K	2.69%	5
2017 Q1	$35.4M	Buy	213,701 +30,330	+17%	+$4.97M	2.46%	7
2016 Q4	$29.8M	Buy	183,371 +56,470	+44%	+$8.44M	2.26%	12
2016 Q3	$17.8M	Sell	126,901 -37,812	-23%	-$5.3M	1.4%	31
2016 Q2	$23.3M	Buy	164,713 +489	+0.3%	+$65.2K	1.81%	24
2016 Q1	$21.2M	Buy	164,224 +16,140	+11%	+$1.91M	1.64%	28
2015 Q4	$17.4M	Buy	148,084 +143,135	+2,892%	+$16.7M	1.32%	34
2015 Q3	$574K	Buy	+4,949	New	+$592K	0.05%	76

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Inverness Counsel's UNH Position: Q3 2022 in Review

Inverness Counsel reduced its UnitedHealth (UNH) stake by 20% in Q3 2022, selling an estimated $14M and leaving 104,795 shares worth $52.9M. The position accounts for 2.94% of the portfolio, ranked #8.

Inverness Counsel first reported a position in UNH in Q3 2015 and has held it in 29 quarters since. The position peaked at $69.4M in Q1 2022. 2,994 funds tracked by Wall St. Rank hold UNH as of Q3 2022.

Inverness Counsel held 104,795 shares of UnitedHealth worth $52.9M as of Q3 2022.
Inverness Counsel sold 26,572 UnitedHealth shares in Q3 2022, an estimated $14M.
UnitedHealth made up 2.94% of Inverness Counsel's portfolio in Q3 2022, its #8 holding.
Inverness Counsel first reported a position in UnitedHealth in Q3 2015 and has held it in 29 quarters since.
Inverness Counsel's UnitedHealth position peaked at $69.4M in Q1 2022.
2,994 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.